Visual Acuity

DENVER — Patients with diabetic macular edema were able to maintain visual acuity improvements long term despite receiving fewer anti-VEGF injections as treatment progressed, according to a study.

DENVER – Pooled phase 3 analyses showed that the use of pilocarpine 1.25% ophthalmic solution increased extended depth of focus 30% the first hour after administration, Chris Lievens, OD, of Southern College of Optometry, said at ARVO.

DENVER — Worse near visual acuity and greater interocular difference in near visual acuity are associated with worse stereoacuity in children, according to a presenter.

DENVER — A higher 8 mg dose of aflibercept for the treatment of wet AMD resulted in patients having a two- or three-letter improvement in visual acuity vs. the traditional 2 mg dose, David Brown, MD, said here at ARVO.

DENVER — Children with amblyopia treated with an at-home device experienced improvement in visual acuity and binocularity, according to a study presented at the Association for Research in Vision and Ophthalmology meeting.

DENVER — In this Healio Video Perspective from the ARVO meeting, Daniel H. Chang, MD, discusses his virtual poster on the duration of Vuity (Allergan) in photopic intermediate visual acuity.

DENVER — High-dose aflibercept maintained visual acuity in patients with neovascular age-related macular degeneration at 48 months, according to a study presented at the Association for Research in Vision and Ophthalmology meeting.

WASHINGTON — A new surgical classification method for cataract blindness resulted in positive visual acuity outcomes and low complication rates, according to a speaker here.

Orasis Pharmaceuticals announced that its phase 3 trials showed patients treated with CSF-1 achieved a statistically significant three-line or more gain in distance-corrected near visual acuity with no loss of distance visual acuity.

The first of two pivotal phase 3 trials that will assess the safety and efficacy of Brimochol PF for the treatment of presbyopia is underway, according to a press release from Visus Therapeutics.